Landmark trials in endocrine adjuvant therapy for breast carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 16435388.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The review summarizes the outcomes of several landmark trials involving aromatase inhibitors that helped formulate current therapeutic approaches recommended by the American Society of Clinical Oncology for breast carcinoma treatment.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Breast Neoplasms
- Clinical Trials as Topic